Gilead's coronavirus drug remdesivir shows progress in monkeys
Fox Business Flash top headlines for April 17
Fox Business Flash top headlines are here. Check out what’s clicking on FoxBusiness.com.
Get all the latest news on coronavirus and more delivered daily to your inbox. Sign up here.
Continue Reading Below
The experimental coronavirus drug remdesivir has recently shown promising results in a small study with infected monkeys, the National Institutes of Health announced Friday.
The study by government scientists in Montana found treatment with the drug, developed by Gilead Sciences, resulted in “significantly better health” for the monkeys that were treated compared to the monkeys that were untreated. Officials noted the findings have not yet faced peer review, the academic process for ensuring the validity of scientific studies.
|GILD||GILEAD SCIENCES INC.||83.99||+7.45||+9.73%|
CORONAVIRUS PATIENTS RESPONDING TO GILEAD DRUG REMDESIVIR: REPORT
Monkeys that were untreated had difficulty breathing and scientists found more damage to their lungs from COVID-19 compared to the treated animals, according to the NIH.
Officials said the data indicates treating COVID-19 patients with the drug as early as possible will help “achieve maximum treatment effect.”
Another trial conducted by the University of Chicago Medicine found most COVID-19 patients given daily treatments of remdesivir were released from the hospital in less than a week. Several other studies are ongoing.